Moreover, to develop an efficient method to deliver the ELAS1 peptide into cancer cells, we prepared a recombinant adenovirus that expressed both ELAS1 and WT p53 protein and found that it efficiently killed p53-deficient SAS cells. Here, TP53 is linked to cancer.